Alpha 1-adrenergic receptors (␣ 1 -ARs) control the activity of dorsal raphe nucleus (DRn) serotonin (5-HT) neurons and play crucial role in the regulation of arousal and stress homoeostasis. However, the precise role of these receptors in regulating glutamate synapses of rat DRn 5-HT neurons and whether chronic stress exposure alters such regulation remain unknown. In the present study, we examined the impact of chronic restraint stress on ␣ 1 -AR-mediated regulation of glutamate synapses onto DRn 5-HT neurons. We found that, in the control condition, activation of ␣ 1 -ARs induced an inward current and long-term depression (LTD) of glutamate synapses of DRn 5-HT neurons. The ␣ 1 -AR LTD was initiated by postsynaptic ␣ 1 -ARs but mediated by a decrease in glutamate release. The presynaptic expression of the ␣ 1 -AR LTD was signaled by retrograde endocannabinoids (eCBs). Importantly, we found that chronic exposure to restraint stress profoundly reduced the magnitude of ␣ 1 -AR LTD but had no effect on the amplitude of ␣ 1 -AR-induced inward current. Chronic restraint stress also reduced the CB1 receptor-mediated inhibition of EPSC and the eCB-mediated depolarization-induced suppression of excitation. Collectively, these results indicate that chronic restraint stress impairs the ␣ 1 -AR LTD by reducing the function of presynaptic CB1 receptors and reveal a novel mechanism by which noradrenaline controls synaptic strength and plasticity in the DRn. They also provide evidence that chronic stress impairs eCB signaling in the DRn, which may contribute, at least in part, to the dysregulation of the stress homeostasis.
Introduction
Serotonin (5-hydroxytryptamine ) neurons in the dorsal raphe nucleus (DRn) (Dahlström and Fuxe, 1964) provide major serotonergic projections to brain areas controlling the behavioral and neuroendocrine responses to stress (Petrov et al., 1994) . By modulating the stress-associated neuronal circuits, DRn 5-HT neurons control stress homeostasis and mood (Joëls and Baram, 2009) . Indeed, animal studies have shown that the behavioral responses to various stressors are mediated, at least in part, by the activation of 5-HT system. For instance, exposure to uncontrollable stressors (e.g., tail shock) activates DRn 5-HT neurons and enhances 5-HT transmission (Amat et al., 1998; Maswood et al., 1998; Grahn et al., 1999) . Activation of DRn 5-HT neurons also regulates uncontrollable stress-induced learned helplessness (Grahn et al., 1999) , characterized by a set of behaviors, including reduced escape to aversive stimuli, increased fear conditioning, and anxiety (Maier et al., 1994 (Maier et al., , 1995 . Conversely, inhibition of DRn 5-HT neurons reduces the behavioral responses to uncontrollable stressors (Maier et al., 1994 (Maier et al., , 1995 , indicating that DRn 5-HT neurons play a key role in modulating the behavioral responses to uncontrollable stress . Furthermore, results from clinical studies have established that stress-induced dysregulation of the 5-HT system is a major contributing factor for the development of mood disorders, such as depression and anxiety (Southwick et al., 2005; Lupien et al., 2009) .
The DRn receives a major noradrenergic input from the locus ceruleus (Baraban and Aghajanian, 1981) , which activates DRn 5-HT neurons (Baraban and Aghajanian, 1981) and regulates arousal and stress homeostasis (Morilak et al., 2005; Stone et al., 2007) . Previous studies have shown that exposure to various stressors increases noradrenaline release in the DRn (Tanaka et al., 1983; Shimizu et al., 1994) and induces anxiety-like behaviors (Chiba et al., 2012; Kim et al., 2012) , at least in part, via the activation of ␣ 1 -ARs located on DRn 5-HT neurons (Stone et al., 2007) . ␣ 1 -AR signaling in the DRn also regulates fear conditioning, as blockade of these receptors prevents conditioned fear and impairs escape performance (Grahn et al., 2002) . Furthermore, disruption of DRn ␣ 1 -AR signaling alters the behavioral effects of antidepressant and antianxiety drugs (O'Leary et al., 2007; Doze et al., 2009) . Collectively, these studies indicate that ␣ 1 -ARmediated control of DRn 5-HT neurons plays an important role in the regulation of stress homoeostasis and that the alteration of ␣ 1 -AR signaling in the DRn might contribute to stress-related mood disorders.
Remarkably, despite the crucial role of ␣ 1 -AR signaling in the DRn in controlling the behavioral responses to stress, the effects of chronic stress on ␣ 1 -AR-mediated control of the excitability of 5-HT neurons and synaptic transmission in the DRn remain unknown. In this study, we show that exposure to chronic restraint stress (CRS) impairs ␣ 1 -AR LTD of glutamate synapses in the DRn but has no effects on ␣ 1 -AR-induced membrane depolarization/inward current in DRn 5-HT neurons. The CRS-induced impairment of ␣ 1 -AR LTD is mediated by a downregulation of eCB signaling. Such results unravel a novel cellular mechanism by which chronic stress could induce long-lasting changes in the function of the 5-HT system.
Materials and Methods
Brain slice preparation. All the experimental procedures used in this study were approved by the University at Buffalo Animal Care and Use Committee and follow the guidelines in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Brain slices containing the DRn were prepared from 6-to 8-week-old male Sprague Dawley rats (Harlan Laboratories) using standard procedures (Haj-Dahmane, 2001 ). In brief, rats were anesthetized with isoflurane and killed by decapitation. The brainstem area was isolated, and coronal sections (300 m) containing the DRn were cut in ice-cold modified ACSF of the following composition (in mM): 110 choline chloride, 2.5 KCl, 0.5 CaCl 2 , 7 MgSO 4 , 1.25 NaH 2 PO 4 , 26.2 NaHCO 3 , 11.6 sodium L-ascorbate, 3.1 sodium pyruvate, 25 glucose, and equilibrated with 95% O 2 /5% CO 2 using a vibrating-blade microtome (Lancer series 1000; Leica Biosystem). Slices were incubated for 45 min at 35°C and then at room temperature for at least 1 h in a holding chamber filled with regular ACSF (in mM): 119 NaCl, 2.5 CaCl 2 , 1.3 MgSO 4 , 1 NaH 2 PO 4 , 26.2 NaHCO 3 , 11 glucose, and continuously bubbled with 95% O 2 /5% CO 2 . After recovery, slices were transferred to a recording chamber (Warner Instruments) mounted on a fixed upright microscope. In the chamber, the slice is continuously perfused (2-3 ml/min) with ACSF saturated with 95% O 2 /5% CO 2 and heated to 30 Ϯ 1°C using a solution heater (Warner Instruments).
Electrophysiological recordings. DRn neurons were visualized using a BX 51 Olympus microscope (Olympus) equipped differential interference contrast and infrared optical filter. Somatic whole-cell recordings were obtained from putative DRn 5-HT neurons with patch electrodes (3-5 M⍀) filled with a solution containing the following (in mM): 120 potassium gluconate, 10 KCl, 10 Na 2 -phosphocreatine, 10 HEPES, 1 MgCl 2 , 1 EGTA, 2 Na 2 -ATP, 0.25 Na-GTP, pH 7.3, osmolarity 280 -290 mOsmol. To examine the role of postsynaptic G-proteins in mediating the effects of ␣ 1 -ARs, GTP was replaced with GDP ␤ S. To examine the depolarization-induced suppression of excitation (DSE) at glutamate synapses of the DRn, whole-cell recordings were performed with patch electrodes filled with cesium methanesulfonate-based solution of the following composition (in mM): 120 cesium methanesulfonate, 10 CsCl, 10 Na 2 -phosphocreatine, 10 HEPES, 1 MgCl 2 , 1 EGTA, 2 Na 2 -ATP, 0.25 Na-GTP, pH 7.3, osmolarity 280 -290 mOsmol. The use of this internal solution facilitates the induction of the DSE in the DRn (Haj-Dahmane and Shen, 2009). DRn 5-HT neurons were identified using previously well established electrophysiological criteria (Haj-Dahmane, 2001 ).
All recordings were performed from neurons located in the dorsomedial and ventromedial subdivisions of the DRn. EPSCs were evoked with single square-pulses (100 -200 s duration) delivered at 0.1 Hz with patch pipettes (3-5 M⍀) filled with ACSF and placed 50 -100 m dorsolateral to the recorded neuron. In some experiments, to assess the change in paired-pulse ratio (PPR), pairs of EPSCs were evoked with an interstimulus interval of 20 -30 ms. The intensity of the stimulus was adjusted to evoke 75% of the maximal amplitude of EPSCs. ␣-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-mediated EPSCs were recorded in neurons voltage-clamped at Ϫ70 mV and in the continuous presence of GABA A and glycine receptor antagonists picrotoxin (100 M) and strychnine (20 M), respectively. To determine the AMPAR/NMDAR ratio, neurons were recorded with cesium methylsulfonate-based internal solution in the presence of GABA A and glycine receptor antagonists and voltage-clamped at 50 mV. EPSCs were recorded in the absence (mixed EPSCs) and presence of APV (50 M: AMPAR-EPSCs). NMDAR-EPSCs were determined by digital subtraction of AMPAR-EPSCs from mixed EPSCs. The AMPAR/NMDAR ratio was determined by dividing the average (30 traces) amplitude of AMPAR-EPSC by the average (30 traces) amplitude of NMDAR-EPSCs. Membrane currents were amplified with an Axoclamp 2B or Multiclamp 700B amplifier (Molecular Devices). The membrane currents were filtered at 3 kHz, digitized at 20 kHz with Digidata 1440, and acquired using the pClamp 10.0 software (Molecular Devices). Access resistance (10 -20 M⍀) was monitored online using 5 mV hyperpolarizing voltage steps (200 ms duration). Recordings were discarded when the access resistance increased by Ͼ10% to 20%.
Stress procedures. The stress paradigm used in this study is the chronic inescapable restraint stress (CRS). Male rats were physically restrained using rodent restrainers (IITC Life Science) for a 45 min session, three times per day for 7 consecutive days. After each session, rats were returned to their home cage. Control animals were handled briefly (5-10 min) for 7 consecutive days. Electrophysiological studies were performed 24 h after the last restraint session.
Data analysis. AMPAR-EPSCs were analyzed using the Clampfit 10.2 software (Molecular Devices). The amplitude of AMPAR-EPSCs was determined by measuring the average current during a 2 ms time window at the peak of each EPSC and subtracted from the baseline current determined during a 5 ms time window before the stimulus artifact. All AMPAR-EPSC amplitudes were normalized to the mean baseline amplitude recorded for at least 10 min before drug application. The PPR (EPSC 2 /EPSC 1 ) was averaged for at least 60 trials in the absence and presence of phenylephrine (PHE). To determine the coefficient of variation (CV) and the SD, the mean amplitude of AMPAR-EPSCs was calculated for at least 60 consecutive trials in control condition and during the LTD. The CV was then given by the following ratio: (SD)/(EPSC mean amplitude). Statistical analysis was performed using the Origin 8.0 software (Microcal Software). The results in the text and figures are expressed as mean Ϯ SEM. Statistical comparisons were conducted using the Student's paired t test for within-group comparisons and the independent t test for comparisons between groups. Statistical significance was set at p Ͻ 0.05.
Chemicals and drugs. Most chemicals were obtained from Fisher Scientific. PHE, prazosin, picrotoxin, strychnine, 
Results

␣ 1 -ARs induce LTD of glutamate synapses in the DRn
To assess the impact of ␣ 1 -ARs on glutamatergic synaptic transmission onto putative DRn 5-HT neurons, we examined the effect the ␣ 1 -AR agonist PHE on the amplitude of AMPAR-EPSCs. As reported previously (Pan et al., 1994) , bath administration of PHE (100 M) induced a significant inward shift of the holding current in all putative DRn 5-HT neurons voltage clamped at their resting membrane potential (i.e., Ϫ70 mV; Fig. 1A ). On average, the amplitude of the PHE-induced inward current (I PHE ) was 53.5 Ϯ 5.9 pA (n ϭ 15). In addition to this postsynaptic effect, PHE (100 M) profoundly reduced the amplitude of evoked AMPAR-EPSCs. A representative experiment depicting the effect of PHE on the amplitude of AMPAR-EPSCs is represented in Figure 1B . On average, PHE (100 M) reduced the amplitude of AMPAR-EPSCs to 36.5 Ϯ 5.2% at the peak of PHE response (Fig. 1D, n ϭ 15) . Washout of PHE resulted in a partial recovery of the amplitude of AMPAR-EPSCs. On average, AMPAR-EPSCs recovered to 58.4 Ϯ 2.9% of baseline after extensive (Ͼ40 min) washout of PHE ( Fig. 1C,D ; n ϭ 15). Treatment of slices with prazosin (10 M), a selective ␣ 1 -AR antagonist, abolished I PHE (n ϭ 8, data not shown) and blocked the acute and the long-lasting depression of AMPA-EPSC amplitude (98.1 Ϯ 8.2% of baseline, n ϭ 8, p Ͻ 0.05; Fig. 2A ), indicating that both the I PHE and the depression of AMPAR-EPSCs are signaled by ␣ 1 -ARs.
Unlike the I PHE , which was reversible after washout of PHE, the depression of AMPAR-EPSC amplitude was long-lasting, suggesting that the persistent depression of AMPA-EPSCs could not be attributed to an incomplete washout of PHE or to a persistent activation of ␣ 1 -ARs. To further test this notion, we examined whether prazosin (10 M) could reverse the ␣ 1 -AR-induced persistent depression of AMPAR-EPSCs. As illustrated in Figure  2B , washout of PHE with prazosin failed to reverse the PHEinduced persistent depression of AMPAR-EPSCs (57.8 Ϯ 7.6% of baseline, n ϭ 8, p Ͻ 0.05; Fig. 2B ). Collectively, these results indicate that the activation of ␣ 1 -ARs induces an LTD of glutamate synapses onto DRn 5-HT neurons.
Previous studies in other brain areas have reported that ␣ 1 -ARs induce LTD of glutamate synapses by postsynaptic mechanisms involving an alteration of the function and/or the subunit composition of AMPARs McElligott and Winder, 2008; McElligott et al., 2010) . To determine the mechanism underlying the ␣ 1 -AR LTD of glutamate synapses in the DRn, we monitored the PPRs of AMPAR-EPSCs, a synaptic parameter inversely correlated with the release probability of neurotransmitters, before and during the PHE-LTD. We found that the ␣ 1 -AR LTD was accompanied by a persistent increase in the PPR ( Fig. 3B ; n ϭ 7). The average PPR increased from 1.10 Ϯ 0.07 in control condition to 1.40 Ϯ 0.06 during the ␣ 1 -AR LTD ( Fig.  3C ; p Ͻ 0.05, n ϭ 7). In addition, the ␣ 1 -AR LTD was also associated with a significant increase in the CV of AMPAR-EPSC amplitude, another synaptic parameter that reflects changes in the probability of neurotransmitter release. The increase in the CV resulted in a decrease in 1/CV 2 ( Fig. 3D ; n ϭ 7), which was correlated with the magnitude of the ␣ 1 -AR LTD. Together, these results indicate that the ␣ 1 -AR LTD of glutamate synapses in the DRn is caused by a decrease in the probability of synaptic glutamate release.
G-protein-driven endocannabinoid production mediates the ␣ 1 -AR LTD in the DRn
In principle, ␣ 1 -AR LTD could be mediated by activation of presynaptic ␣ 1 -ARs, which could induce a persistent decrease in glutamate release. Alternatively, it is possible that the LTD could be initiated by the activation of postsynaptic ␣ 1 -ARs but mediated presynaptically via retrograde messengers. To determine whether presynaptic or postsynaptic ␣ 1 -ARs mediate the LTD, we examined the effect of inhibiting postsynaptic ␣ 1 -AR signaling with intracellular application of the membrane impermeable G-proteins inhibitor GDP ␤ S on the ␣ 1 -AR LTD. To ensure that this manipulation was effective in blocking postsynaptic ␣ 1 -ARs, we also monitored the amplitude of I PHE , a response signaled by postsynaptic ␣ 1 -ARs. As expected for a postsynaptic response, intracellular application of GDP ␤ S (250 M) totally blocked I PHE ( Fig initiates the LTD induction. Such results, along with the observation that ␣ 1 -AR LTD is caused by a persistent decrease in glutamate release, also imply that the presynaptic expression of ␣ 1 -AR LTD is mediated by retrograde messengers.
Classically, ␣ 1 -ARs are coupled to the canonical G q-11 /PLC ␤ signaling cascade. Activation of this signaling cascade elicits the hydrolysis of phosphatidylinositol (4,5) biphosphate (PIP2) and the formation of 1,2 diacyl-glycerol (1,2-DAG) (Cotecchia et al., 1992; Wu et al., 1992 Wu et al., , 1995 , a major precursor of the eCB 2-arachidonyl-glycerol (2-AG) (Stella et al., 1997) . Because stimulation of G q-11 coupled receptors enhances the synthesis/release of 2-AG (Maejima et al., 2001; Kim et al., 2002; Ohno-Shosaku et al., 2003; Haj-Dahmane and Shen, 2005) , which mediates retrograde modulation of synaptic transmission and plasticity via presynaptic CB1 receptors (Katona and Freund, 2012) , we hypothesized that the ␣ 1 -AR LTD in the DRn is most likely mediated by retrograde eCB signaling. To test this hypothesis, we examined the effect of CB1 receptor antagonist AM 251 on the magnitude of ␣ 1 -AR LTD. We found that treatment of brain slices with AM 251 (3 M), a manipulation that has been shown to block CB1 receptor-mediated inhibition of glutamate release in the DRn (Haj-Dahmane and Shen, 2005, 2009) , strongly reduced the acute depression of AMPAR-EPSCs induced by PHE (100 M) (control ϭ 41.7 Ϯ 2.9% of baseline; AM 251 ϭ 82.3 Ϯ 7.3% of baseline; p Ͻ 0.05, n ϭ 8) and the magnitude of ␣ 1 -AR LTD (control ϭ 57.9 Ϯ 6.5% of baseline; AM 251 ϭ 89.9 Ϯ 8.9% of baseline; p Ͻ 0.05, n ϭ 8; Fig. 5B ). In contrast, blockade of CB1 receptors had no significant effect on the amplitude of I PHE (I PHE control ϭ 56.5 Ϯ 8.9 pA; I PHE AM 251 ϭ 53.89 Ϯ 6.8 pA; n ϭ 8, p Ͼ 0.05; data not shown), indicating that the inhibition of ␣ 1 -AR-mediated acute depression of AMPAR-EPSCs and LTD induced by AM 251 could not be attributed to a blockade of ␣ 1 -AR signaling, but to a blockade of CB1 receptors. These results also suggest that the ␣ 1 -AR LTD in the DRn is mediated by retrograde eCBs acting through presynaptic CB1 receptors.
To determine whether 2-AG was the eCB messenger that mediated the acute inhibition of AMPAR-EPSCs and the LTD induced by ␣ 1 -ARs, we explored the effects of inhibiting sn-1-diacylglycerol lipase (DGL-␣/␤), an enzyme that converts 1,2-DAG into 2-AG, on the ␣ 1 -AR-induced acute inhibition of AMPAR-EPSCs and LTD. We found that treatment of brain slices with THL (10 M), a DGL-␣/␤ inhibitor, profoundly reduced the acute depression of AMPAR-EPSCs induced by PHE (100 M, THL ϭ 86.3 Ϯ 5.5% of baseline, n ϭ 8, p Ͻ 0.05). Blockade of a DGL-␣/␤ also abolished the ␣ 1 -AR-LTD induced by PHE (control ϭ 64.11 Ϯ 3.4% of baseline; THL ϭ 96.8 Ϯ 8.6% of baseline; Fig. 5B ; n ϭ 8, p Ͻ 0.05). These results suggest that DGL-␣/␤ is required for both the acute depression of AMPAREPSCs and the LTD induced by activation of ␣ 1 -ARs. Importantly, such results also indicate that 2-AG is the most likely retrograde messenger that mediates ␣ 1 -AR LTD in DRn 5-HT neurons.
We next tested whether a sustained increase in 2-AG release and activation of CB1 receptors are necessary for the maintenance of the ␣ 1 -AR LTD. To that end, we examined the effect of AM 251 on the duration and magnitude of the ␣ 1 -AR LTD after it was initiated. As illustrated in Figure 5E , administration of AM 251 (3 M) after initiation of ␣ 1 -AR LTD induced by bath application of PHE (100 M) failed to reverse and reduce the magnitude of the LTD ( Fig. 5E ; 58.3 Ϯ 8.4% of baseline, p Ͼ 0.05, n ϭ 6). Similarly, administration of the DGL-␣/␤ inhibitor THL (10 M) after initiation of the ␣ 1 -AR LTD did not alter the time course or the magnitude of the LTD (n ϭ 3; data not shown). Collectively, these results indicate that the maintenance of the ␣ 1 -AR LTD is not mediated by a sustained increase in tonic 2-AG release and persistent activation of CB1 receptors. Instead, these findings indicate that a transient activation of CB1 receptors triggers a persistent decrease in the probability of glutamate release, which mediates the LTD.
Chronic restraint stress impairs the ␣ 1 -AR LTD in DRn 5-HT neurons
Exposure to CRS is known to increase noradrenaline release in the DRn, which regulates the behavioral responses to stress, at least in part, via ␣ 1 -AR signaling (Tanaka et al., 1983; Shimizu et al., 1994) . More importantly, behavioral studies have suggested that alterations of ␣ 1 -AR signaling in the DRn contribute to chronic stress-induced anxiety and depression-like behaviors (Christiansen et al., 2011; Chiba et al., 2012; Kim et al., 2012) . However, the impact of chronic stress, including restraint stress on the function of ␣ 1 -ARs in the DRn, remains unknown. Therefore, we explored the effect of exposure to CRS on the ␣ 1 -ARmediated control of the strength and plasticity of glutamate synapses onto DRn 5-HT neurons. To that end, we first examined the impact of CRS on the baseline glutamate release and the overall strength of glutamate synapses. As illustrated in Figure  6A , we found that exposure to CRS did not significantly affect the PPR (PPR control ϭ 1.13 Ϯ 0.03, n ϭ 12; PPR stress ϭ 1.11 Ϯ 0.06; n ϭ 12), indicating that exposure to CRS had no significant effect on the probability of glutamate release in the DRn. Similarly, CRS had no significant effect on the AMPA/NMDA ratio (AMPA/NMDA control ϭ 0.842 Ϯ 0.12, n ϭ 11; AMPA/NMDA stress ϭ 0.796 Ϯ 0.13; Fig. 6B ; n ϭ 11), a measure of the strength of glutamate synapses, indicating that CRS did not alter the overall strength of glutamate synapses impinging onto DRn 5-HT neurons. We next examined the impact of CRS on the ␣ 1 -ARinduced acute depression of AMPR-EPSCs and LTD. Compared with the control condition, we found that CRS exposure significantly reduced the acute depression of AMPAR-EPSCs induced by PHE (100 M). On average, the amplitude of AMPAR-EPSCs was reduced to 50.4 Ϯ 6.8% and 76.9 Ϯ 4.6% of baseline in control and CRS-exposed rats, respectively ( Fig. 6C,D ; n ϭ 13, p Ͻ 0.05). CRS exposure also significantly reduced the magnitude of ␣ 1 -AR LTD (Fig. 6C,D; 89.3 Ϯ 9.7% of baseline, p Ͻ 0.05, n ϭ 13). Increasing the concentration of PHE to 300 M still failed to increase the magnitude of the ␣ 1 -AR LTD (data not shown; n ϭ 4). In contrast to CRS, acute exposure to restraint stress did not significantly affect the magnitude ␣ 1 -AR LTD (control ϭ 62.5 Ϯ 7.5% of baseline; acute restraint ϭ 65.3 Ϯ 8.5 of baseline p Ͼ 0.05 vs control; data not shown). Collectively, these results indicate that exposure to CRS impairs the ability of the ␣ 1 -ARs to control the strength and plasticity of glutamate synapses onto DRn 5-HT neurons.
Results from previous studies have reported that chronic exposure to stress or to corticosterone downregulates ␣-adrenoceptors in the brain areas controlling stress homeostasis (Joëls and de Kloet, 1989; Miyahara et al., 1999) . Therefore, it is possible that the CRS-induced impairment of ␣ 1 -AR LTD could be attributed to an alteration of ␣ 1 -AR function in the DRn. To test this possibility, we monitored the effect of CRS on the amplitude of the I PHE , a response signaled by the activation of ␣ 1 -ARs. Surprisingly, we found that exposure to CRS, which strongly inhibited the magnitude of the ␣ 1 -AR LTD ( Fig. 6C ; n ϭ 13), failed to alter the amplitude of I PHE (I PHE control ϭ 32.17 Ϯ 3.9 pA; I PHE CRS ϭ 29.22 Ϯ 5.2 pA; Fig. 6D ; n ϭ 13). Such results suggest that the CRS-induced inhibition of the ␣ 1 -AR LTD is unlikely to be attributed to downregulation/desensitization of DRn ␣ 1 -ARs. However, it remains possible that alterations of downstream signaling cascade from ␣ 1 -ARs could mediate the CRS-induced inhibition of the ␣ 1 -AR LTD.
Because the ␣ 1 -AR LTD is signaled by an increase in eCB synthesis/release and the subsequent activation of presynaptic CB1 receptors, CRS could inhibit the magnitude of the LTD by reducing the ␣ 1 -AR-driven eCB synthesis or by downregulating presynaptic CB1 receptors. If the CRS-induced inhibition of ␣ 1 -AR LTD were to be mediated by a reduction in eCB synthesis/ release, CRS should have no significant effect on the depression of AMPAR-EPSCs induced by exogenous CB1 receptor agonists. We tested this notion by examining the effect of CRS on the inhibition of AMPA-EPSCs induced by WIN 55212-2, a CB1 receptor agonist (Haj-Dahmane and Shen, 2009). We found that, compared with control, CRS exposure markedly reduced the ability of WIN 55212-2 (10 M) to inhibit AMPAR-EPSCs. On average, bath application of WIN 55212-2 reduced the amplitude of AMPAR-EPSCs to 46.8 Ϯ 4.5% of baseline ( Fig. 7A ; n ϭ 13) and 88.89 Ϯ 9.8% of baseline in control and CRS-exposed rats ( Fig. 7A ; n ϭ 12, p Ͻ 0.01, unpaired t test), respectively. Detailed dose-response curves of the inhibition of AMPAR-EPSCs revealed that the efficacy of high (3, 10, and 30 M), but not low concentrations (0.1 and 1 M) of WIN 55212-2 was significantly reduced in CRS-exposed rats compared with control ( Fig. 7B ; n ϭ 8). These results support the idea that the impairment of the ␣ 1 -AR LTD after CRS exposure can be attributed to functional downregulation of presynaptic CB1 receptors.
To further test that a downregulation of presynaptic CB1 receptors mediates the CRS-induced impairment of ␣ 1 -AR LTD, we also examined the impact of CRS exposure on the magnitude of the eCB-mediated DSE, a CB1 receptor-mediated short-term synaptic plasticity (Haj-Dahmane and Shen, 2009) . Consistent with previous reports (Haj-Dahmane and Shen, 2009), in slices from control rats, a brief (5 s) depolarization (from Ϫ70 to 0 mV) of DRn 5-HT neurons elicited a robust DSE (DSE control ϭ 53.5 Ϯ 4.7% of baseline, n ϭ 12; Fig. 7C ). Remarkably, exposures to CRS profoundly reduced the magnitude of the DSE (DSE stress ϭ 89.9 Ϯ 3.5% of baseline, p Ͻ 0.05, n ϭ 12; Fig. 7C ). These results, along with the observation that CRS reduces the efficacy of CB1 agonist to inhibit the amplitude of AMPAR-EPSCs, strongly indicate that CRS impairs ␣ 1 -AR LTD by reducing the function of presynaptic CB1 receptors.
Discussion
The present study shows that activation of ␣ 1 -ARs elicits LTD of glutamate synapses onto DRn 5-HT neurons. This form of synaptic plasticity is initiated by the activation of postsynaptic ␣ 1 -ARs but expressed presynaptically by a decrease in glutamate release. The ␣ 1 -AR LTD is signaled by retrograde eCB messengers acting on presynaptic CB1 receptors. More importantly, we report that exposure to CRS profoundly reduces of the magnitude of ␣ 1 -AR LTD. The CRS-induced impairment of ␣ 1 -AR LTD is essentially mediated by a downregulation of presynaptic CB1 receptors. As such, our study reveals a novel cellular mechanism by which noradrenaline controls the function of DRn 5-HT. It also provides the first direct evidence that chronic stress reduces eCB signaling at glutamate synapses of DRn 5-HT neurons, which could have important functional implications for stress-induced maladaptation of the 5-HT system.
Previous studies have examined the regulation of glutamate synapses by ␣ 1 -ARs in various brain areas (Scanziani et al., 1993; Scheiderer et al., 2004; Choi et al., 2005; McElligott and Winder, 2008; Marzo et al., 2010; McElligot et al., 2010) . Generally, these studies have reported that activation of ␣ 1 -ARs elicits a transient inhibition of glutamatergic transmission. However, in some brain areas, such as the cerebral cortex (e.g., visual cortex and prefrontal cortex), hippocampus, and the bed nucleus of striata terminalis, activation of ␣ 1 -ARs induces LTD of glutamate synapses (Scheiderer et al., 2004; Choi et al., 2005; McElligott and Winder, 2008; Marzo et al., 2010; McElligot et al., 2010) . Depending on the brain area studied, the ␣ 1 -AR LTD seems to be mediated by different cellular mechanisms. In the hippocampus and cerebral cortex, the ␣ 1 -AR LTD is mediated by a postsynaptic mechanism that involves ␣ 1 -AR-induced activation of the extracellular signal regulating kinase (ERK1/2) pathways (Scheiderer et al., 2008; Marzo et al., 2010) . Activation of ERK 1/2 induces LTD by reducing the function and/or number of AMPARs. At glutamate synapses of the bed nucleus of striata terminalis, the ␣ 1 -AR LTD is mediated by a switch of the subunit composition of glutamate release as indicated by the increase in PPR and CV. Finally, blockade of presynaptic CB1 receptors or inhibition of 2-AG synthesis abolishes the ␣ 1 -AR LTD. The conclusion that the ␣ 1 -AR LTD of glutamate synapses onto DRn 5-HT neurons is mediated by 2-AG acting at presynaptic CB1 receptors is consistent with numerous studies showing that activation of G q/11 -coupled receptors, such as Group I metabotropic glutamate receptors (mGluR1/5), M1/M5 muscarinic receptors, and orexin receptors, increase the synthesis/release of 2-AG in various brain areas (Maejima et al., 2001; Kim et al., 2002; Ohno-Shosaku et al., 2003) , including the DRn (Haj-Dahmane and Shen, 2005). Generally, G q/11 coupled receptor-driven 2-AG synthesis and release mediate transient inhibition of excitatory and inhibitory synaptic transmission (Maejima et al., 2001; Kim et al., 2002; HajDahmane and Shen, 2005) . However, growing evidence indicates that this mode of 2-AG synthesis/release also mediates the presynaptic form of LTD at glutamate and GABA synapses and, hence, plays an ubiquitous role in regulating synaptic plasticity in the brain (Castillo et al., 2012) .
Results from previous studies have reported that chronic exposure to various stressors increases the expression in the DRn of various synaptic proteins, such as synaptosomal-associated protein 25 and synaptic vesicle glycoprotein 2B (Abumaria et al., 2006 (Abumaria et al., , 2007 , suggesting that chronic stress can induce a longlasting alteration of synaptic function and plasticity in the DRn. Consistent with this idea, we report that CRS impairs the ␣ 1 -AR LTD of glutamate synapses onto DRn 5-HT neurons. The alteration of ␣ 1 -AR-mediated synaptic plasticity in the DRn may represent an important cellular mechanism by which chronic stress can induce a long-lasting alteration of the 5-HT system. The effects of restraint stress on the ␣ 1 -AR-mediated control of synaptic transmission have also been examined in several other brain areas. In the amygdala, exposure to acute restraint stress combined with tail shock blocks the ␣ 1 -AR-mediated facilitation of GABA-ergic transmission (Braga et al., 2004) . The mechanisms underlying this effect remain unknown. Here, we find that acute exposure to restraint stress has no effect on the ability of ␣ 1 -ARs to control the function of glutamate synapses. In contrast, exposure to CRS profoundly impairs the ␣ 1 -AR LTD of glutamate synapses in the DRn by blocking the induction and maintenance of the LTD. Such finding is in agreement with a previous study showing that exposure to CRS, but not to acute restraint stress, also impairs the LTD of glutamate synapses induced by ␣ 1 -ARs (McElligott et al., 2010) in the basal nucleus of striata terminalis. Collectively, these studies suggest that the impairment of the ␣ 1 -AR-mediated control of the strength and plasticity of glutamate synapses may represent a common response to chronic stress exposure. Importantly, such alterations of synaptic plasticity may mediate the maladaptive behavioral responses to chronic stress, including depression and anxiety.
An interesting finding of the present study is that exposure to CRS has no significant effect on the amplitude of the ␣ 1 -ARinduced inward current but reduces the effect of presynaptic CB1 receptors on glutamate release. These results strongly indicate (2) the LTD in control slices (left) and in slices from CRS-exposed rats (right). Calibration: 50 pA, 10 ms. Bottom, Summary of the time course and magnitude of the inhibition of AMPAR-EPSC amplitude induced by PHE (100 M) in control (white circles, n ϭ 14) and CRS-exposed rats (red circles, n ϭ 13). D, Summary histograms of the acute effect and LTD induced by PHE (100 M) obtained in control (open bars) and in CRS-exposed rats (filled bars). CRS significantly reduces the acute depression of AMPAR-EPSC and the LTD. *p Ͻ 0.05. E, Summary graph of the average amplitude of I PHE induced by PHE (100 M) in control (white circles, n ϭ 12) and CRS-exposed rats (red circles, n ϭ 13). Exposure to CRS has no significant effect on the amplitude of I PHE ( p Ͼ 0.05).
that the CRS-induced impairment of the ␣ 1 -AR LTD is not mediated by a downregulation of ␣ 1 -ARs but by a profound reduction of presynaptic CB1 receptor function. However, it remains possible that CRS could also reduce eCB synthesis/release, which may contribute to the impairment of the ␣ 1 -AR LTD. The conclusion that CRS reduces the function of presynaptic CB1 receptors is consistent with previous studies showing that chronic exposure to various stressors, including CRS, downregulates CB1 receptors and impairs eCB-mediated control of glutamatergic (Rossi et al., 2008; Wang et al., 2010; Reich et al., 2013) and GABAergic synaptic transmission in other brain areas (Wamsteeker et al., 2010; Hu et al., 2011) . Importantly, in the nucleus accumbens, exposure to chronic stress has also been shown to block the eCB-mediated LTD induced by mGluR1 at glutamate synapses onto medium spiny neurons (Wang et al., 2010) . As in the DRn, the blockade of the mGluR1 LTD is mainly attributed to a reduction of presynaptic CB1 receptor function (Wang et al., 2010) . Together, the results of these studies indicate that reduced retrograde eCB signaling (e.g., downregulation of CB1 receptors) may represent a common mechanism by which chronic stress impairs G q/11 -coupled receptor-mediated control of synaptic function and plasticity in the brain. Although exposure to chronic stress has been shown to impair the function of presynaptic CB1 receptors in various brain areas (Hill et al., 2005; Wang et al., 2010) , the precise molecular mechanisms underlying this effect remain unknown. It is well established that exposure to chronic stress increases the circulating levels of corticosterone and noradrenaline (Krugers et al., 2012) . Because both of these stress mediators stimulate eCB synthesis and release in the DRn (Wang et al., 2012 ; present study) and other brain areas (Di et al., 2003) , it is tempting to speculate that the high circulating levels of noradrenaline and corticosterone during daily stress lead to chronic increase in eCB release and activation of CB1 receptors, which could induce downregulation of these receptors. Consistent with this idea, results from previous studies have shown that chronic exposure to stress enhances the release of 2-AG in various brain regions (Patel and Hillard, 2008; Patel et al., 2009 ). More importantly, chronic activation of CB1 receptors with eCBs or exogenous cannabinoids has been shown to reduce the function of presynaptic CB1 receptors (Sim et al., 1996; Breivogel et al., 1999) . Thus, it is possible that the CRS-induced functional downregulation of presynaptic CB1 receptors reported in this study could be attributed to an agonistinduced downregulation. However, future studies are required to further test this notion and determine the precise cellular mechanisms underlying the downregulation of presynaptic CB1 receptors.
Extensive work has established that noradrenergic inputs from the locus ceruleus provide a major excitatory drive to the Figure 7. Exposure to CRS impairs the function of presynaptic CB1 receptors in the DRn. A, CRS reduces the ability of presynaptic CB1 receptors to inhibit glutamate release. Top, Superimposed AMPA-EPSCs taken before and during bath application of the CB1 receptor agonist WIN 55212-2 (10 M) in control (left) and CRS-exposed rats (right). Calibration: 50 pA, 10 ms. Bottom, Summary graph of the inhibition of AMPA-EPSC amplitude induced by WIN 55212-2 (10 M) in control (white circles, n ϭ 13) and CRS-exposed rats (red circles, n ϭ 10). CRS exposure profoundly reduces the efficacy of WIN 55212-2 in inhibiting the amplitude of AMPAR-EPSCs. B, Dose-response curves of the effect of WIN 55212-2 on AMPAR-EPSCs obtained in control (white circles) and CRS-exposed rats (red circles). **p Ͻ 0.01. C, Exposure to CRS profoundly reduces the magnitude of the eCB-mediated DSE. Left, DSE induced in control (white circles, n ϭ 14) and CRS-exposed rats (red circles, n ϭ 12). Right, Superimposed AMPAR-EPSCs traces taken before and during the DSE in putative DRn 5-HT neurons from control and CRS-exposed rats. Calibration: 50 pA, 10 ms.
DRn, which is mediated by ␣ 1 -ARs. Activation of these receptors increases the excitability of DRn 5-HT neurons by inducing membrane depolarization (Aghajanian, 1985; Pan et al., 1994) and reducing the amplitude of after hyperpolarizing potential (Pan et al., 1994) . In addition to these excitatory effects, the present study shows that activation of postsynaptic ␣ 1 -ARs enhances 2-AG release, which in turn reduces the strength of glutamate synapses onto DRn 5-HT neurons (Fig. 8) . Combined, these studies indicate that the noradrenergic modulation of 5-HT neurons is more complex than initially thought and that ␣ 1 -AR signaling in the DRn exerts a bidirectional control on the excitability of 5-HT neurons. The bidirectional control exerted by ␣ 1 -AR could play an important role in maintaining the activity of 5-HT neurons within desirable range and prevent excessive excitation of DRn 5-HT neurons, especially during heightened arousal (e.g., stress), which is characterized by increased noradrenergic tone (Krugers et al., 2012) . As such, the reduction of eCB signaling and the impairment of ␣ 1 -AR LTD induced by chronic stress may lead to an abnormal increase in the excitability of DRn 5-HT neurons and persistent alteration of central 5-HT transmission. Furthermore, the impairment of eCB signaling in the DRn could mediate, at least in part, some of the behavioral consequences of chronic stress exposure, such as depression-like behaviors. It is noteworthy that pharmacological manipulation that increases eCB signaling has been shown to block chronic stress-induced depression-like behaviors (Zhong et al., 2014) .
